在阿尔茨海默氏症疾病中,APP处理的氨基原性途径的潜在调节者
Daria Krawczuk1, Agnieszka Kulczyńska-Przybik1, Barbara Mroczko1,2
1Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Białystok, Poland.
阿尔茨海默病涉及粉样蛋白前体蛋白 (APP) 处理,产生有毒的粉样β (Aβ) . 本综述探讨了调节APP粉样原体路径的因素,这对于了解疾病进展和早期生物标志物发展至关重要.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 的发病与粉样蛋白前体蛋白 (APP) 处理有关.
- 从APP聚合物中生成的氨基甲基β (Aβ) ,形成有毒的大脑斑块.
- 了解APP处理是AD病理学和早期生物标志物发现的关键.
研究的目的:
- 调查调节APP处理的粉基路径的关键因素.
- 为了提高对阿尔茨海默病分子机制的理解.
主要方法:
- 这是一篇综述性文章,综合了现有研究.
- 专注于影响粉胺基因APP处理途径的因素.
主要成果:
- 氨基原蛋白 APP 处理途径是由酶,蛋白质和信号通路的复杂相互作用调节的.
- 影响这种途径的特定因素对阿尔茨海默病的发展和进展至关重要.
结论:
- 调查调节APP处理的因素为阿尔茨海默氏症病理学提供了洞察力.
- 这些知识可能有助于开发阿尔茨海默病早期诊断生物标志物.
更多相关视频
06:40Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
Published on: January 25, 2018
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
相关概念视频
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Neural Regulation
